Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL [Phase 1]
Phase 1 randomized, placebo-controlled, dose-escalation safety study of MEDI4212 in subjects with IgE ≥ 30 IU/mL has completed and results h…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Efficacy and Safety of a a Biofunctional Textile in the Management of Atopic Dermatitis [Phase 2]
This completed Phase 2 clinical trial evaluated the efficacy and safety of a biofunctional textile for the management of atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens [Phase 4]
Phase 4 trial assessing the efficacy of montelukast in atopic dermatitis induced by food allergens. Results were posted in 2014.
-
CLINICAL_TRIALS withdrawal · 2014-12-02Clinical Trial Update: Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients [NA]
The clinical trial evaluating pioglitazone for skin barrier function in atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202) [Phase 3]
Phase 3 efficacy and safety results for desloratadine (MK-4117) in Japanese participants with eczema/dermatitis and dermal pruritus have bee…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-11-11Clinical Trial Update: Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis [Phase 3]
This clinical trial update covers a Phase 3 study of a topical amino acid moisturizing cream combined with desonide for atopic dermatitis. T…
-
FDA approval · 2014-10-30FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for hydrocortisone butyrate from Oceanside Pharmaceuticals, expanding its regulatory status under ND…
-
FDA label_change · 2014-10-30FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for hydrocortisone butyrate from Oceanside Pharmaceuticals, resulting in changes to the product labe…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Study of 0416 Ointment in the Treatment of Atopic Dermatitis [Phase 3]
Phase 3 study of 0416 ointment for atopic dermatitis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Study of 0417 Ointment in the Treatment of Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating 0417 Ointment for atopic dermatitis has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Distribution of Tacrolimus in Skin, Atopic Dermatitis [Phase 2]
This Phase 2 study reports on the distribution of tacrolimus in the skin of patients with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Long-term Safety of Protopic in Atopic Eczema [Phase 3]
This Phase 3 clinical trial update summarizes long-term safety findings for Protopic (tacrolimus) in atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis [Phase 2]
This Phase 2 trial in children with atopic dermatitis compares tacrolimus ointment to a steroid ointment regimen to assess equivalence in tr…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment [Phase 3]
A Phase 3 study evaluating 0.03% tacrolimus ointment for atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis [Phase 4]
This Phase 4 trial compares tacrolimus ointment (Protopic) with pimecrolimus cream (Elidel) in pediatric patients with mild atopic dermatiti…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis [Phase 4]
Phase 4 trial comparing tacrolimus ointment to pimecrolimus cream for atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis [Phase 4]
A multi-center Phase 4 study evaluated short- and long-term use of Protopic ointment (tacrolimus) for atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis [Phase 4]
Phase 4 trial comparing tacrolimus ointment (Protopic) with pimecrolimus cream (Elidel) in pediatric atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment [Phase 3]
A Phase 3 trial evaluating 0.1% tacrolimus ointment for the treatment of atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians
A completed clinical trial assessing the place of Flixovate in the treatment pathway and conditions of use for atopic dermatitis in infants …
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus
Post-marketing surveillance of Alesion in Japanese pediatric patients with allergic rhinitis, atopic dermatitis (eczema/dermatitis), urticar…
-
FDA approval · 2014-09-09FDA Approved: TACROLIMUS — Original Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
FDA approved a generic tacrolimus topical product under an original application; it is indicated for the treatment of atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis [Phase 2]
Phase 2 trial update reporting long-term safety data for tacrolimus ointment in young children with atopic dermatitis. The study has complet…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 trial in pediatric patients with moderate to severe atopic dermatitis assessed the response and safety of 0.03% tacrolimus ointmen…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating tacrolimus ointment at 0.1% and 0.03% for adults with moderate to severe atopic dermatitis has completed, assessi…